Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
RSC Advances|May 24, 2023
Lonicera japonica Thunb. as a promising antibacterial agent for Bacillus cereus ATCC14579 based on network pharmacology, metabolomics, and in vitro experimentsNan Xu, Li-Hua Du, Yan-Chao Chen, et al.
Genome Research|March 16, 2021
Improved redox homeostasis owing to the up-regulation of one-carbon metabolism and related pathways is crucial for yeast heterosis at high temperatureLiang Song, Jun-Yan Shi, Shou-Fu Duan, et al.
Mycokeys|December 1, 2025
Penicillium and Talaromyces diversity in cystic fibrosis patient sample and the description of a new species, Penicillium subluteum sp. nov. (Eurotiales, Aspergillaceae)Ya Bin Zhou, Eelco F J Meijer, Tobias G P Engel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 7, 2009
Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese populationJian-Jun Yan, Na-Ping Tang, Jian-Jin Tang, et al.
RSC Advances|April 10, 2024
Correction: Lonicera japonica Thunb. as a promising antibacterial agent for Bacillus cereus ATCC14579 based on network pharmacology, metabolomics, and in vitro experimentsNan Xu, Li-Hua Du, Yan-Chao Chen, et al.
Yeast (Chichester, England)|December 28, 2021
Highly diverged lineages of Saccharomyces paradoxus in temperate to subtropical climate zones in ChinaPeng-Yu He, Xu-Qian Shao, Shou-Fu Duan, et al.
Journal of Asian Natural Products Research|July 17, 2018
Transcriptome analysis of three cultivars of Poria cocos reveals genes related to the biosynthesis of polysaccharidesLan Yang, Juan Tang, Jin-Jun Chen, et al.
Frontiers in Microbiology|February 28, 2022
Proposal of Two New Combinations, Twenty New Species, Four New Genera, One New Family, and One New Order for the Anamorphic Basidiomycetous Yeast Species in UstilaginomycotinaYao-Yao Li, Man-Man Wang, Marizeth Groenewald, et al.
Molecular Biology Reports|April 13, 2010
A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery diseaseLian-Sheng Wang, Jian-Jun Yan, Na-Ping Tang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 29, 2017
Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced MacrophagesYa-Fei Li, Hao Wang, Yi Fan, et al.
Pageof 14